Plerixafor (Mozobil): A Stem Cell-Mobilizing Agent for Transplantation in Lymphoma Patients Predicted to Be Poor Mobilizers - A Pilot Study

Publisher： Karger

E-ISSN： 1421-9662|135|1|29-36

ISSN： 0001-5792

Source： Acta Haematologica, Vol.135, Iss.1, 2015-0, pp. : 29-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 275-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 81-87

John Wiley & Sons Inc

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation in Mantle Cell Lymphoma: A Retrospective Analysis of 7 Patients

By  

Oncology, Vol. 89, Iss. 2, 2015-04 ,pp. : 118-123

Karger

Access to resources Recommend Favorite

Autologous stem cell transplantation outcomes in elderly patients with B cell Non‐Hodgkin Lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 2, 2015-10 ,pp. : 197-204

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autologous stem cell transplantation outcomes in elderly patients with B cell Non‐Hodgkin Lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 2, 2015-10 ,pp. : 197-204

John Wiley & Sons Inc

Access to resources Recommend Favorite